403 related articles for article (PubMed ID: 26054568)
1. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.
Behl T; Kotwani A
Pharmacol Res; 2015 Sep; 99():137-48. PubMed ID: 26054568
[TBL] [Abstract][Full Text] [Related]
2. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
3. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
5. [Cell biology of intraocular vascular diseases].
Ishibashi T
Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
[TBL] [Abstract][Full Text] [Related]
6. Role of leukotrienes in diabetic retinopathy.
Behl T; Kaur I; Kotwani A
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():1-9. PubMed ID: 26673555
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Liou GI; Caldwell RW
Curr Drug Targets; 2005 Jun; 6(4):511-24. PubMed ID: 16026270
[TBL] [Abstract][Full Text] [Related]
8. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
9. Diabetic retinopathy and angiogenesis.
Crawford TN; Alfaro DV; Kerrison JB; Jablon EP
Curr Diabetes Rev; 2009 Feb; 5(1):8-13. PubMed ID: 19199892
[TBL] [Abstract][Full Text] [Related]
10. Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.
Lu QY; Chen W; Lu L; Zheng Z; Xu X
Int J Clin Exp Pathol; 2014; 7(10):7268-77. PubMed ID: 25400825
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
[TBL] [Abstract][Full Text] [Related]
12. Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction.
Bento CF; Fernandes R; Matafome P; Sena C; Seiça R; Pereira P
Exp Physiol; 2010 Sep; 95(9):955-70. PubMed ID: 20562294
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
14. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.
Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML
Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.
Capitão M; Soares R
J Cell Biochem; 2016 Nov; 117(11):2443-53. PubMed ID: 27128219
[TBL] [Abstract][Full Text] [Related]
16. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic growth factors and their inhibitors in diabetic retinopathy.
Praidou A; Androudi S; Brazitikos P; Karakiulakis G; Papakonstantinou E; Dimitrakos S
Curr Diabetes Rev; 2010 Sep; 6(5):304-12. PubMed ID: 20594164
[TBL] [Abstract][Full Text] [Related]
19. p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy.
Zou W; Zhang Z; Luo S; Cheng L; Huang X; Ding N; Yu J; Pan Y; Wu Z
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319515
[TBL] [Abstract][Full Text] [Related]
20. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Lee IG; Chae SL; Kim JC
Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
